Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Myocardial Stunning

ClinicalTrials.gov lists 19 trials for Myocardial Stunning or a narrower condition beneath it. Vastra Gotaland Region has the most among industry and government lead sponsors, with 2.

MeSH D017682 Cardiovascular Diseases C14 C23
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 2 Phase 1/2 Phase 1/2 1 Phase 4 Phase 4 3 Not applicable Not applicable 6 Observational Observational 7 Phase 1 Phase 1 2 Phase 1/2 Phase 1/2 1 Phase 4 Phase 4 3 Not applicable Not applicable 6 Observational Observational 7

Trials per phase

19 of the 19 trials are tagged with Myocardial Stunning itself; the rest are tagged with a narrower condition beneath it.

Get the Myocardial Stunning report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Myocardial Stunning trials start? (12)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 4

1996: 1 trials (Observational 1) 2003: 1 trials (Observational 1) 2005: 1 trials (Observational 1) 2010: 1 trials (Not applicable 1) 2015: 2 trials (Not applicable 1, Phase 4 1) 2018: 1 trials (Phase 4 1) 2019: 4 trials (Observational 3, Phase 4 1) 2021: 2 trials (Not applicable 2) 2022: 3 trials (Observational 1, Not applicable 1, Phase 1/2 1) 2023: 1 trials (Phase 1 1) 2024: 1 trials (Phase 1 1) 2025: 1 trials (Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2025 1
2024 1
2023 1
2022 3
2021 2
2019 4
2018 1
2015 2
2010 1
2005 1

No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 19 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Myocardial Stunning trials in? (5)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 2
Phase 1/2 1
Phase 4 3
Not applicable 6
Observational 7

How many Myocardial Stunning trials are recruiting? (5)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 1
Completed 9
Terminated 2
Withdrawn 3
Unknown status 4

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Myocardial Stunning trials? (2)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Vastra Gotaland Region 2
National Heart, Lung, and Blood Institute (NHLBI) 1

Which drugs are being tested for Myocardial Stunning? (4)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
DIAZOXIDE 2
Ranolazine 1
Levosimendan 1
Cyanocobalamin 1

Interventions as named in the registry (5)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Control (placebo) group 1
continuous renal replacement therapy 1
Exercise 1
aspirin, clopidogrel, ticagrelor, atorvastatin, rosuvastatin, betaloc 1
mitochondria and MSC-derived exosomes 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Myocardial Stunning? (50)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Cardioprotective Effect of Acute Intradialytic Exercise: A Comprehensive Speckle-Tracking Echocardiography Analysis. Journal of the American Society of Nephrology : JASN 2023 Yes
Assessment of stunned and viable myocardium using manganese-enhanced MRI. Open heart 2021 Yes
Translational large animal model of hibernating myocardium: characterization by serial multimodal imaging. Basic research in cardiology 2020 Yes
Intradialytic exercise preconditioning: an exploratory study on the effect on myocardial stunning. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2019 Yes
Brain-Heart Interactions in Traumatic Brain Injury. Cardiology in review 2017 Yes

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages